Curtiss-Wright Earnings Call Transcripts
Fiscal Year 2026
-
Management highlighted strong financial performance, driven by innovation, operational excellence, and targeted R&D. Growth is expected across defense, nuclear, and aerospace, with robust pipelines in U.S. and Europe. Capital deployment supports future expansion and shareholder returns.
-
Naval and defense electronics segments are experiencing robust growth, supported by increased government investment, strong order books, and expanding international and nuclear opportunities. AP1000 and SMR projects are set to drive future revenue, while disciplined capital allocation supports ongoing expansion.
-
Q1 2026 results exceeded expectations with 13% sales growth and 23% EPS growth, prompting raised full-year guidance for sales, margins, and free cash flow. Record order book and strong segment performance, especially in defense and nuclear, support a positive outlook.
Fiscal Year 2025
-
Record 2025 results featured double-digit growth in sales, EPS, and free cash flow, with robust order momentum and margin expansion. 2026 guidance projects continued growth, margin improvement, and record cash flow, supported by strong A&D and commercial nuclear demand.
-
Aerospace, defense, and nuclear segments are driving strong growth, with commercial aerospace and defense electronics leading in margins and innovation. New U.S. and NATO spending, exclusive AP1000 reactor content, and SMR opportunities support robust forward-looking projections.
-
Delivered 9% sales growth and 14% operating income growth with record backlog and margin expansion. Raised 2025 guidance for sales, EPS, and Free Cash Flow, supported by strong demand in A&D and commercial nuclear markets, and accelerated share repurchases.
-
Defense and nuclear markets are driving robust growth, with strong positions in shipbuilding, defense electronics, and commercial nuclear. FAA mandates and SMR partnerships add new growth vectors, while disciplined M&A and capital deployment support long-term expansion.
-
Q2 2025 delivered double-digit sales and earnings growth, record backlog, and raised full-year guidance for sales, margins, EPS, and free cash flow. Defense and commercial nuclear markets drive robust outlook, with strong capital returns and disciplined M&A focus.
-
A multi-year growth strategy is driving strong financial results, with expanding R&D, margin gains, and a focus on high-value end markets like defense and nuclear. New opportunities in Eastern Europe and small modular reactors are set to further boost growth.
-
Management highlighted strong organic growth, margin expansion, and robust free cash flow, driven by defense, commercial aerospace, and nuclear segments. International sales and new mandates in flight recorders and nuclear projects are set to accelerate growth, with a healthy M&A pipeline and continued capital returns.
-
Q1 2025 results exceeded expectations with 13% sales growth and 34% higher operating income, prompting raised full-year guidance for sales, margins, and EPS. Record backlog and strong order intake support confidence, while tariff risks are largely mitigated.
Fiscal Year 2024
-
Record 2024 results featured double-digit sales and EPS growth, robust order book, and strong free cash flow. 2025 guidance projects 7%-8% sales growth, double-digit EPS increase, and continued margin expansion, supported by acquisitions and strong A&D and nuclear demand.
-
Management outlined a strategy focused on margin expansion, increased R&D, and operational maturity, with ambitious growth targets in both commercial nuclear and defense. Nuclear business is set to double by 2028, supported by aftermarket and new build opportunities, while strong free cash flow enables continued acquisitions and shareholder returns.
-
Q3 2024 saw 10% sales growth, 11% higher operating income, and a record $3.3B backlog, prompting raised full-year guidance for sales, EPS, and free cash flow. Defense electronics and commercial nuclear markets drove results, with strong capital allocation and strategic acquisitions supporting future growth.
-
Management highlighted strong execution of past growth targets, new ambitious three-year goals, and robust market drivers in defense, commercial nuclear, and subsea pumps. Strategic investments in R&D, operational excellence, and targeted M&A underpin confidence in sustained growth and margin expansion.
-
Celebrating 95 years on the NYSE, the company is accelerating growth through its Pivot to Growth strategy, targeting a 5%+ organic revenue CAGR and ongoing margin expansion. Defense and commercial segments are set for robust growth, with nuclear and aerospace benefiting from secular trends and strategic acquisitions.
-
Q2 2024 saw 11% sales growth, 16% higher operating income, and 24% EPS growth, with strong performance across all segments and a record backlog. Guidance for 2024 was raised, supported by robust order activity, a major acquisition, and ongoing restructuring and efficiency initiatives.
-
A global engineering firm highlighted its strong legacy, operational excellence, and innovation-driven growth, achieving robust financial results and setting ambitious targets. Strategic acquisitions and investments in R&D and digital tools position it for significant expansion, especially in the commercial nuclear sector and SMRs.
-
Margin expansion and disciplined R&D investment support ongoing growth, with strong visibility in defense and commercial nuclear markets. Recent acquisitions and strategic partnerships, including with NVIDIA, enhance innovation and geographic reach. Nuclear and defense opportunities are expected to drive long-term value.